PF-05089771 (tosylate) Chemical Properties

storage temp. 

room temp

solubility 

DMF: 33 mg/ml; DMSO: 33 mg/ml; DMSO:PBS(pH 7.2) (1:4): 0.20 mg/ml

form 

powder

color 

white to beige

PF-05089771 (tosylate) Usage And Synthesis

Description

PF-05089771 is a voltage-gated sodium channel 1.7 (Na_v1.7) blocker (IC₅₀s = 11, 16, 33, and 20 nM for 5N11S, 5A11L, 5A11S, and 5A11L Na_v1.7 splice variants, respectively). It is selective for Na_v1.7 over Na_v1.1-1.6 and 1.8 channels (IC₅₀s = 0.11-25 μM), L-type calcium, and K_vLQT and hERG potassium channels (IC₅₀s = ≥10 μM), as well as human and cynomolgus monkey TRPV1 receptors (IC₅₀s = 10 and 20 μM, respectively). PF-05089771 is also 1,000-fold selective for half-inactivated over resting Na_v1.7 channels, and mutation of the domain IV voltage-sensor domain (VSD4) reduces PF-05089771 potency by approximately 100-fold.

Biochem/physiol Actions

PF-05089771 is a selective and potent inhibitor of the human voltage-gated sodium ion channel Nav1.7 with an IC50 value of 11 nM. PF-05089771 targets the voltage-sensing domain, preferentially interacting with, and stabilizing, inactivated channel conformations by interaction with the voltage-sensor domain (VSD) of Domain 4. Nav1.7 is expressed in sensory neurons and is critical for pain processing. PF-05089771 is being investigated for the treatment of chronic neuropathic pain.

storage

Desiccate at RT

PF-05089771 (tosylate)(1430806-04-4)Related Product Information

• PF-06700841 tosylate
• PF-06650833
• PF-06424439
• PF-06447475
• PF 3644022
• PF 04995274
• PF-3084014
• PF 573228
• PF-06882961
• PF-5190457
• PF-05212384
• [(3R)-1-[2-[1-(4-Chloro-1H-pyrazol-1-yl)cyclopropyl]-3H-imidazo[4,5-b]pyridin-5-yl]-3-piperidinyl]-1-pyrrolidinyl-methanone methanesulfonate
• PF-04691502
• 1H-Indole-2-carboxamide, 4-methoxy-N-[(1S)-3-methyl-1-[[[(1S)-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]-3-(phosphonooxy)propyl]amino]carbonyl]butyl]-
• PF 477736